title: Pomalidomide for symptomatic Kaposi's sarcoma.
authors.forename: Talha Khan
authors.initials: TK
authors.lastname: Burki
mesh_terms: D000074322:Antineoplastic Agents, Immunological / Q000009:adverse effects / Q000627:therapeutic use*; D017321:Clinical Trials, Phase I as Topic; D017322:Clinical Trials, Phase II as Topic; D006801:Humans; D012514:Sarcoma, Kaposi / Q000188:drug therapy* / Q000473:pathology; D012878:Skin Neoplasms / Q000188:drug therapy* / Q000473:pathology; D013792:Thalidomide / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000627:therapeutic use; D016896:Treatment Outcome
chemical_list: D000074322:Antineoplastic Agents, Immunological; D013792:Thalidomide; C467566:pomalidomide